$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg

$hcsg Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000073101215000045 Filed on April 23, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$355.2M	$312.2M
YoY Change	13.8%	13.97%
Cost Of Revenue	$303.9M	$267.4M
YoY Change	13.68%	13.68%
Gross Profit	$51.31M	$44.79M
YoY Change	14.55%	15.71%
Gross Profit Margin	14.44%	14.35%
Selling, General & Admin	$26.76M	$22.05M
YoY Change	21.4%	6.04%
% of Gross Profit	52.16%	49.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.911M	$1.757M
YoY Change	8.76%	29.96%
% of Gross Profit	3.72%	3.92%
Operating Expenses	$26.76M	$22.05M
YoY Change	21.4%	6.04%
Operating Profit	$24.55M	$22.75M
YoY Change	7.91%	26.92%
Interest Expense	$500.0K	$400.0K
YoY Change	25.0%	-60.0%
% of Operating Profit	2.04%	1.76%
Other Income/Expense, Net
YoY Change
Pretax Income	$25.05M	$23.13M
YoY Change	8.32%	22.01%
Income Tax	$9.538M	$8.490M
% Of Pretax Income	38.07%	36.71%
Net Earnings	$15.52M	$14.64M
YoY Change	5.99%	-2.11%
Net Earnings / Revenue	4.37%	4.69%
Basic Earnings Per Share	$0.22	$0.21
Diluted Earnings Per Share	$0.22	$0.21
COMMON SHARES
Basic Shares Outstanding	71.47M shares	70.32M shares
Diluted Shares Outstanding	72.16M shares	71.07M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.10M	$83.34M
YoY Change	-15.89%	7.83%
Cash & Equivalents	$58.29M	$71.69M
Short-Term Investments	$11.90M	$11.65M
Other Short-Term Assets	$13.20M	$12.80M
YoY Change	3.13%	11.3%
Inventory	$35.40M	$32.80M
Prepaid Expenses	$11.03M	$11.81M
Receivables	$211.4M	$195.1M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$330.3M	$324.1M
YoY Change	1.91%	21.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.06M	$11.83M
YoY Change	10.46%	15.17%
Goodwill	$44.44M	$40.18M
YoY Change	10.59%	137.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$38.00K	$38.00K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$132.0M	$117.1M
YoY Change	12.74%	77.79%
TOTAL ASSETS
Total Short-Term Assets	$330.3M	$324.1M
Total Long-Term Assets	$132.0M	$117.1M
Total Assets	$462.3M	$441.1M
YoY Change	4.79%	32.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.64M	$47.99M
YoY Change	-11.13%	56.6%
Accrued Expenses	$51.10M	$56.70M
YoY Change	-9.88%	125.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$99.97M	$105.8M
YoY Change	-5.51%	85.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$77.20M	$41.60M
YoY Change	85.58%	18.18%
Total Long-Term Liabilities	$77.20M	$41.60M
YoY Change	85.58%	18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$99.97M	$105.8M
Total Long-Term Liabilities	$77.20M	$41.60M
Total Liabilities	$177.2M	$147.3M
YoY Change	20.3%	59.76%
SHAREHOLDERS EQUITY
Retained Earnings	$103.1M	$130.0M
YoY Change	-20.71%	-0.43%
Common Stock	$192.8M	$174.8M
YoY Change	10.3%	44.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.85M	$11.08M
YoY Change	-2.03%	-2.22%
Treasury Stock Shares	1.759M shares	1.828M shares
Shareholders Equity	$285.1M	$293.8M
YoY Change
Total Liabilities & Shareholders Equity	$462.3M	$441.1M
YoY Change	4.79%	32.72%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	$15.52M	$14.64M
YoY Change	5.99%	-2.11%
Depreciation, Depletion And Amortization	$1.911M	$1.757M
YoY Change	8.76%	29.96%
Cash From Operating Activities	-$6.204M	$18.32M
YoY Change	-133.86%	-464.43%
INVESTING ACTIVITIES
Capital Expenditures	$1.436M	$1.513M
YoY Change	-5.09%	56.3%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	-$200.0K
YoY Change	-50.0%	-83.33%
Cash From Investing Activities	-$1.538M	-$1.742M
YoY Change	-11.71%	-19.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$26.00K	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$9.246M	-$9.041M
YoY Change	2.27%	28.44%
NET CHANGE
Cash From Operating Activities	-$6.204M	$18.32M
Cash From Investing Activities	-$1.538M	-$1.742M
Cash From Financing Activities	-$9.246M	-$9.041M
Net Change In Cash	-$16.99M	$7.537M
YoY Change	-325.39%	-153.0%
FREE CASH FLOW
Cash From Operating Activities	-$6.204M	$18.32M
Capital Expenditures	$1.436M	$1.513M
Free Cash Flow	-$7.640M	$16.81M
YoY Change	-145.46%	-380.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000731012
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71485000	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE SERVICES GROUP INC
CY2014Q4	hcsg	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	4041000	USD
CY2015Q1	hcsg	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	4557000	USD
CY2014Q4	hcsg	Available For Sale Securities Debt Maturities After Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue	3415000	USD
CY2015Q1	hcsg	Available For Sale Securities Debt Maturities After Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue	3713000	USD
CY2014Q1	hcsg	Common Stock Weighted Average Dividends Per Share Cash Paid CommonStockWeightedAverageDividendsPerShareCashPaid	0.17
CY2015Q1	hcsg	Common Stock Weighted Average Dividends Per Share Cash Paid CommonStockWeightedAverageDividendsPerShareCashPaid	0.18
CY2014Q1	hcsg	Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans	3075000	USD
CY2015Q1	hcsg	Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans	525000	USD
CY2015Q1	hcsg	Description For Terms Of Service Agreement DescriptionForTermsOfServiceAgreement	Our agreements with clients typically provide for a one year service term, cancelable by either party upon 30 to 90 days’ notice after the initial 90-day period.
CY2014Q4	hcsg	Housekeeping Equipment And Office Furniture Gross HousekeepingEquipmentAndOfficeFurnitureGross	33546000	USD
CY2015Q1	hcsg	Housekeeping Equipment And Office Furniture Gross HousekeepingEquipmentAndOfficeFurnitureGross	34539000	USD
CY2014Q1	hcsg	Increase Decrease In Deferred Compensation Funding IncreaseDecreaseInDeferredCompensationFunding	798000	USD
CY2015Q1	hcsg	Increase Decrease In Deferred Compensation Funding IncreaseDecreaseInDeferredCompensationFunding	-451000	USD
CY2015Q1	hcsg	Line Of Credit Facility Number Of Financial Covenants LineOfCreditFacilityNumberOfFinancialCovenants	1	financial_covenant
CY2015Q1	hcsg	Lineof Credit Facility Increase Decrease Remaining Borrowing Capacity LineofCreditFacilityIncreaseDecreaseRemainingBorrowingCapacity	-71415000	USD
CY2011Q4	hcsg	Percentage Of Reduction To Medicare Payments To Nursing Centers PercentageOfReductionToMedicarePaymentsToNursingCenters	0.111
CY2015Q1	hcsg	Percentage Of Revenue And Income Earned In One Geographic Segment PercentageOfRevenueAndIncomeEarnedInOneGeographicSegment	0.99
CY2015Q1	hcsg	Period Of Amortization Of Inventories And Supplies PeriodOfAmortizationOfInventoriesAndSupplies	P24M
CY2014Q1	hcsg	Related Party Transaction Fees Paid Related Party As Percentage Of Overall Related Party Revenues RelatedPartyTransactionFeesPaidRelatedPartyAsPercentageOfOverallRelatedPartyRevenues	0.05
CY2015Q1	hcsg	Related Party Transaction Fees Paid Related Party As Percentage Of Overall Related Party Revenues RelatedPartyTransactionFeesPaidRelatedPartyAsPercentageOfOverallRelatedPartyRevenues	0.05
CY2015Q1	hcsg	Service Agreements Duration Of Service ServiceAgreementsDurationOfService	P1Y
CY2015Q1	hcsg	Service Agreements Initial Period ServiceAgreementsInitialPeriod	P90D
CY2014Q1	hcsg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodTotalFairValue	2051000	USD
CY2015Q1	hcsg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodTotalFairValue	2719000	USD
CY2015Q1	hcsg	Share Based Compensation Arrangement By Share Based Payment Award Maximum Term Of Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumTermOfGrants	P10Y
CY2014Q1	hcsg	Share Based Compensation Arrangement By Share Based Payment Award Options Grants Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsGrantDateFairValue	4268000	USD
CY2015Q1	hcsg	Share Based Compensation Arrangement By Share Based Payment Award Options Grants Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsGrantDateFairValue	4027000	USD
CY2014Q1	hcsg	Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice	25.87
CY2015Q1	hcsg	Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice	29.22
CY2014Q1	hcsg	Unrealized Gain Loss On Securities Related To Deferred Compensation Fund UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund	264000	USD
CY2015Q1	hcsg	Unrealized Gain Loss On Securities Related To Deferred Compensation Fund UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund	365000	USD
CY2014Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	198128000	USD
CY2015Q1	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	211412000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	43554000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	42644000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6179000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23584000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24411000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	25000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	28000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	186022000	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	192068000	USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	777000	USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	499000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	762000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	884000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6136000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4352000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	828000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	810000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	993000	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1014000	shares
CY2014Q4	us-gaap	Assets Assets	469579000	USD
CY2015Q1	us-gaap	Assets Assets	462251000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	334828000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	330251000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	48000	USD
CY2015Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	49000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7000	USD
CY2015Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	11758000	USD
CY2015Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	11808000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	4343000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3585000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11799000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11855000	USD
CY2015Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	3000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64155000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71692000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75280000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58292000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7537000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16988000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4488000	shares
CY2015Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.17625
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72878000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73218000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72878000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73218000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	729000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	732000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14640000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15519000	USD
CY2014Q1	us-gaap	Cost Of Services CostOfServices	267371000	USD
CY2015Q1	us-gaap	Cost Of Services CostOfServices	303936000	USD
CY2015Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2014Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	25276000	USD
CY2015Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	24492000	USD
CY2014Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	24742000	USD
CY2015Q1	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	24291000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	3455000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	2246000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	27233000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	27914000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1757000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1911000	USD
CY2015Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	12655000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.37
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.31
CY2015Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.38
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47696000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25370000	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8523000	USD
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	9363000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	477000	USD
CY2015Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	499000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16232000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17042000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4308000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3241000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2432000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2130000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2130000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2328000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2970000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36581000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36581000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20349000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19539000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	44438000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	44438000	USD
CY2014	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2015Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23129000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	25054000	USD
CY2014Q1	us-gaap	Income Loss From Extraordinary Items Net Of Tax Per Basic Share IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare	0.00
CY2015Q1	us-gaap	Income Loss From Extraordinary Items Net Of Tax Per Basic Share IncomeLossFromExtraordinaryItemsNetOfTaxPerBasicShare	0.00
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8490000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9538000	USD
CY2014Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7821000	USD
CY2015Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1424000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	6855000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	11746000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1878000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6179000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	1230000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	76000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	309000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-44000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-469000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2351000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	9679000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-21002000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2106000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1235000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	1007000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-912000	USD
CY2014Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	26000	USD
CY2015Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	2979000	USD
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	751000	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	690000	shares
CY2014Q1	us-gaap	Interest Paid InterestPaid	13000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	22000	USD
CY2014Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	88000	USD
CY2015Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	93000	USD
CY2014Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	381000	USD
CY2015Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	507000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	469579000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	462251000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	117959000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	99969000	USD
CY2015Q1	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2015Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2018-12-18
CY2015Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	125000000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2578000	USD
CY2015Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2727000	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11799000	USD
CY2015Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11855000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9041000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9246000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1742000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1538000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18320000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6204000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	14639000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	15516000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14639000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15516000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14639000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	15516000	USD
CY2014Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	5179000	USD
CY2015Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	2716000	USD
CY2015Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2015Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	48	state
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8961000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7253000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	1000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3000	USD
CY2014Q4	us-gaap	Other Inventory OtherInventory	35462000	USD
CY2015Q1	us-gaap	Other Inventory OtherInventory	35418000	USD
CY2014Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	12077000	USD
CY2015Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	12655000	USD
CY2014Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1228000	USD
CY2015Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	989000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1513000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1436000	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9792000	USD
CY2015Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11028000	USD
CY2014Q4	us-gaap	Prepaid Taxes PrepaidTaxes	912000	USD
CY2015Q1	us-gaap	Prepaid Taxes PrepaidTaxes	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26000	USD
CY2014Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	939000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	846000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	871000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	758000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	60000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	41000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2559000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2884000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36356000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37475000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12772000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13064000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	232000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	209000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	750000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	925000	USD
CY2014Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1000	USD
CY2015Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3000	USD
CY2015Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2000	USD
CY2014Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	120000	USD
CY2015Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	120000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	100237000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	103098000	USD
CY2014Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	312165000	USD
CY2015Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	355246000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22046000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.024
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.022
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	884000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26763000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	762000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.369
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.272
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1748000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	22000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	26.26
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	561000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	561000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.24
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.64
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2362000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2740000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.45
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.69
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	18.21
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	30.30
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1465000	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1516000	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	22000	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	6.51
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.17
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.66
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	488000	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.17
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	161000	shares
CY2015Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	26000	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	491000	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1851000	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1701000	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2884000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	275830000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	285072000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1821000	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1759000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11183000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	10854000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71072000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72159000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70321000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71469000	shares
CY2014Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	17748000	USD
CY2015Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	18523000	USD
CY2014Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	50514000	USD
CY2015Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	52718000	USD
CY2015Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments, as defined by U.S. GAAP, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. We define our marketable securities as fixed income investments which are highly liquid investments that can be readily purchased or sold using established markets. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, substantially all of our cash and cash equivalents, and marketable securities were held in one large financial institution located in the United States.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our clients are concentrated in the health care industry, primarily providers of long-term care. Many of our clients’ revenues are highly contingent on Medicare, Medicaid and third party payors’ reimbursement funding rates. Congress has enacted a number of major laws during the past decade that have significantly altered, or threatened to alter, overall government reimbursement for nursing home services. These changes and lack of substantive reimbursement funding rate reform legislation, as well as other trends in the long-term care industry have affected and could adversely affect the liquidity of our clients, resulting in their inability to make payments to us on agreed upon payment terms. These factors, in addition to delays in payments from clients, could result in significant additional bad debts in the future.</font></div></div>
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates in Financial Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing financial statements in conformity with U.S. GAAP, we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are used for, but not limited to, our allowance for doubtful accounts, accrued insurance claims, asset valuations and review for potential impairment, and deferred taxes. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information. We regularly evaluate this information to determine if it is necessary to update the basis for our estimates and to compensate for known changes.</font></div></div>

Files In Submission

Name	View Source	Status
0000731012-15-000045-index-headers.html	Edgar Link	pending
0000731012-15-000045-index.html	Edgar Link	pending
0000731012-15-000045.txt	Edgar Link	pending
0000731012-15-000045-xbrl.zip	Edgar Link	pending
ceosection302certification.htm	Edgar Link	pending
cfosection302certification.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hcsg-20150331.xml	Edgar Link	completed
hcsg-20150331.xsd	Edgar Link	pending
hcsg-20150331_cal.xml	Edgar Link	unprocessable
hcsg-20150331_def.xml	Edgar Link	unprocessable
hcsg-20150331_lab.xml	Edgar Link	unprocessable
hcsg-20150331_pre.xml	Edgar Link	unprocessable
hcsg10qq12015.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
section906certificationq12.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg

2015 Q1 Form 10-Q Financial Statement

#000073101215000045 Filed on April 23, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCSG HEALTHCARE SERVICES GROUP INC Stock $hcsg

2015 Q1 Form 10-Q Financial Statement

#000073101215000045 Filed on April 23, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg